InvestorsHub Logo
Followers 1
Posts 232
Boards Moderated 0
Alias Born 01/23/2014

Re: None

Wednesday, 01/29/2014 10:36:05 PM

Wednesday, January 29, 2014 10:36:05 PM

Post# of 716893
E-mailed those Biopharmcataylst yehoos. I asked them about the NWBO date situation.

Got a response surprisingly (nothing too new, just solidifies):

Hi FatCat_Banker,

Thank you for your message.

The removal of the NWBO interim analysis was an ERROR. I apologise for that but I inadvertently removed the wrong catalyst.

It's now back in the database but may take about an hour or so to actually appear.

The entry is as follows:

NWBO 4.83 144967716 Phase 3 2/4/2014 Feedback from Data Monitoring Committee due late January or early February 2014 regarding interim analysis of the Phase 3 trial of DCVax for Glioblastoma multiforme (GBM) brain cancer

SOURCE: http://nwbio.com/first-interim-analysis-of-nw-bios-phase-iii-gbm-trial-triggered-by-reaching-required-number-of-events/

I've put Feb 4 as an estimate only. In their PR on Dec 10 they gave guidance for a release in 6-8 weeks, so Feb 4 = 8 weeks.

Regards,

Dude




It's funny because he makes it sound like it was just a mess up, but we all know the date was originally set for tomorrow. I think he/they knew it likely wouldn't occur within their posted time frame so they pushed it to the end of possibility - to sound dramatic (I'm tired).

So yeah, nothing deep and conspiracy-esque from their end.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News